Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Equity (Details) - Schedule of stock-based compensation expense

v3.22.1
Shareholders' Equity (Details) - Schedule of stock-based compensation expense - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Schedule of stock-based compensation expense [Abstract]    
Research and development options expense $ 76,390 $ 66,631
Total research and development expenses 76,390 66,631
General and administrative options and warrants expense 490,799 407,156
Stock issued to consultants and employees 416,423 850,900
Total general and administrative expenses 907,222 1,258,056
Total stock-based compensation expense $ 983,612 $ 1,324,687